Your browser doesn't support javascript.
loading
Validation of Cutaneous Dermatomyositis Disease Area and Severity Index Activity Score and Other Efficacy Outcomes as Measures of Skin Disease in Dermatomyositis in the Lenabasum Phase 3 Trial.
Pandya, Rachita; Dan, Joshua; Kleitsch, Julianne; White, Barbara; Werth, Victoria P.
Afiliación
  • Pandya R; Corporal Micheal J. Crescenz Department of Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Dan J; Corporal Micheal J. Crescenz Department of Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Kleitsch J; Corporal Micheal J. Crescenz Department of Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • White B; Corbus Pharmaceuticals, Norwood, Massachusetts, USA.
  • Werth VP; Corporal Micheal J. Crescenz Department of Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Electronic address: werth@pennmedicine.upenn.edu.
J Invest Dermatol ; 143(12): 2378-2385.e7, 2023 12.
Article en En | MEDLINE | ID: mdl-37331616

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Dermatomiositis Aspecto: Patient_preference Límite: Adult / Humans Idioma: En Revista: J Invest Dermatol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Dermatomiositis Aspecto: Patient_preference Límite: Adult / Humans Idioma: En Revista: J Invest Dermatol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
...